Paediatric (6-17 years) research study in episodic migraine

Recruitment for this study is currently on hold. This page will be updated when recruitment reopens. 

What is the purpose of the study?

Amgen is currently running a migraine paediatric study in the UK. It is currently recruiting 6–17 year olds with episodic migraine.

If you choose to participate, and if the study is right for you, you will be in this study for about five months where you will receive either investigational medicine or placebo.

Following this, there will be an optional 40-week extension phase during which all patients will receive the investigational medicine.

Who can take part?

6–17 year olds with episodic migraine

What will the study involve?

The patient will be in this study for about five months where they will receive either investigational medicine or placebo.

Following this, there will be an optional 40-week extension phase during which all patients will receive the investigational medicine.

Added: 11 November 2024 | Deadline to sign up: 12 February 2026